Palani Dinesh
Overview
Explore the profile of Palani Dinesh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
203
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Luo X, Qiu Y, Dinesh P, Gong W, Jiang L, Feng X, et al.
J Cell Mol Med
. 2021 Feb;
25(5):2333-2341.
PMID: 33605033
Autophagy is frequently induced in the hypoxic tumour microenvironment. Accumulating evidence reveals important functions of autophagy at the tumour-immune interface. Herein, we propose an update on the roles of autophagy...
2.
Dinesh P, Kalaiselvan S, Sujitha S, Rasool M
Inflammation
. 2020 Sep;
44(1):229-242.
PMID: 32876895
Inflammation is a complex biological process which alters the normal physiological function of the immune system resulting in an abnormal microenvironment that leads to several clinical complications. The process of...
3.
Dinesh P, Kalaiselvan S, Sujitha S, Rasool M
J Cell Physiol
. 2020 May;
235(12):9497-9509.
PMID: 32372426
Bone erosion is the major cause of deformities in autoimmune disease conditions such as osteoporosis and rheumatoid arthritis. Aberrant receptor activator of nuclear factor kappa B ligand (RANKL) secretion in...
4.
Dinesh P, Kalaiselvan S, Sujitha S, Rasool M
Int Immunopharmacol
. 2020 Feb;
82:106328.
PMID: 32088641
Fibroblast-like synoviocytes (FLS) lining the arthritic synovial joint region have been implicated to be a key player in bone remodeling. The uncontrolled proliferation of this cell subtype is strictly regulated...
5.
Sujitha S, Dinesh P, Rasool M
Eur J Pharm Biopharm
. 2020 Feb;
149:170-191.
PMID: 32068029
Bone erosion is a debilitating pathological process of osteopathic disorder like rheumatoid arthritis (RA). Current treatment strategies render low disease activity but with disease recurrence. To find an alternative, we...
6.
Dinesh P, Rasool M
Apoptosis
. 2019 May;
24(7-8):644-661.
PMID: 31111379
In our previous study, we explored the therapeutic effect of berberine (BBR) against IL-21/IL-21R mediated inflammatory proliferation of adjuvant-induced arthritic fibroblast-like synoviocytes (AA-FLS) through the PI3K/Akt pathway. The current study...
7.
Sujitha S, Dinesh P, Rasool M
Toxicol Appl Pharmacol
. 2018 Sep;
359:34-46.
PMID: 30240693
The current study was designed to explore the underlying therapeutic effect of berberine (BBR), an alkaloid compound against LPS (1 μg/ml)/TNFα (10 ng/ml) mediated apoptosis signal-regulating kinase 1 (ASK1) signaling...
8.
Dinesh P, Rasool M
Pharmacol Res
. 2018 Jun;
134:31-39.
PMID: 29859810
Rheumatoid arthritis (RA) is a systemic and chronic autoimmune inflammatory disorder affecting multiple joints. Various cytokines, chemokines and growth factors synergistically modulate the joint physiology leading to bone erosion and...
9.
Dinesh P, Rasool M
Cytokine
. 2018 Mar;
106:54-66.
PMID: 29549724
The current study investigated the therapeutic effect of berberine (BBR), an alkaloid derivative against IL-21/IL-21R mediated phosphotidyl inositol 3 kinase/protein kinase B (PI3K/Akt) signaling in adjuvant induced arthritic fibroblast-like synoviocytes...
10.
Dinesh P, Rasool M
J Cell Physiol
. 2017 Aug;
233(5):3918-3928.
PMID: 28833093
Rheumatoid arthritis (RA) is a systemic autoimmune inflammatory disorder designated with hyperplastic synovium, bone destruction and cartilage degradation. Current therapies involve targeting major cytokines and inflammatory mediators involved in RA...